Neogen Raises FY2027 Sales Guidance from $880.000M-$885.000M to $885.000M-$890.000M vs $883.175M Est

10/6/2026
Impact: 70
Healthcare

Neogen (NASDAQ: NEOG) has raised its sales guidance for FY2027 from a range of $880 million-$885 million to $885 million-$890 million, surpassing the previous estimate of $883.175 million. This adjustment reflects a positive outlook for the company's financial performance.

AI summary, not financial advice

Share: